PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22909976-0	2012	K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.	Oxaliplatin	126-137	KRAS proto-oncogene, GTPase	Homo sapiens	0-5	
22909976-7	2012	Multivariate analysis revealed a predictive significance for K-Ras mutations with respect to time to progression in patients treated with irinotecan and oxaliplatin as first-line chemotherapy.	Oxaliplatin	153-164	KRAS proto-oncogene, GTPase	Homo sapiens	61-66	
22909976-11	2012	Also, K-Ras mutation status may predict time to progression in patients treated with irinotecan and oxaliplatin.	Oxaliplatin	100-111	KRAS proto-oncogene, GTPase	Homo sapiens	6-11